AGL agilon health, inc.
NYSE · SEC CIK 1831097 · EDGAR
- Bought, last 12 months
- $351.0K 5 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 204 since 2021-07-16, latest 2026-08-18 17:44
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Shaker Benjamin | Chief Markets Off | $300.0K | — |
| Wulf John William | Dir | $51.0K | — |
| O'Rourke Timothy Patrick | CEO, Pres, Dir | — | — |
| Zamore Denise | CLO | — | — |
| Gertsch Timothy | CAO | — | — |
| Venkatachaliah Girish | CTO | — | — |
| Battaglia Silvana | Dir | — | — |
| MCKENZIE DIANA | Dir | — | — |
| McLoughlin Karen | Dir | — | — |
| Schwaneke Jeffrey A. | CFO | — | — |
Transactions 298
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-09 | 2024-01-05 | AGL | WILLIAMS RONALD A | Dir | M - OptEx | $1.27 | +1.10M | 3.41M | +48% | +$1.40M |
| 2023-11-30 | 2023-11-29 | AGL | Schwaneke Jeffrey A. | Dir | P - Purchase | $11.22 | +22.3K | 31.9K | +232% | +$250.2K | |
| I | 2023-11-21 | 2023-11-21 | AGL | Sell Steven | CEO, Pres, Dir | P - Purchase | $11.14 | +44.7K | 47.6K | +1,541% | +$497.8K |
| DM | 2023-09-14 | 2023-09-12+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $18.02 | -37.5K | 79.5K | -32% | -$675.9K |
| DM | 2023-09-14 | 2023-09-12+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.79 | +37.5K | 98.3K | +62% | +$142.1K |
| DM | 2023-09-13 | 2023-09-11 | AGL | Gertsch Timothy | CAO | M - OptEx | $7.49 | +26.2K | 25.9K | New | +$196.7K |
| DM | 2023-09-13 | 2023-09-11 | AGL | Gertsch Timothy | CAO | S - Sale+OE | $18.62 | -26.2K | 17.1K | -61% | -$488.7K |
| D | 2023-08-18 | 2023-08-16 | AGL | Gertsch Timothy | CAO | A - Grant | $0.00 | +5,603 | 17.1K | +49% | $0 |
| DM | 2023-08-16 | 2023-08-14+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $18.41 | -37.5K | 79.5K | -32% | -$690.4K |
| DM | 2023-08-16 | 2023-08-14+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.79 | +37.5K | 98.3K | +62% | +$142.1K |
| DM | 2023-07-14 | 2023-07-12+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.79 | +37.5K | 98.3K | +62% | +$142.1K |
| DM | 2023-07-14 | 2023-07-12+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $16.95 | -37.5K | 79.5K | -32% | -$635.6K |
| D | 2023-06-26 | 2023-06-22 | AGL | Battaglia Silvana | Dir | A - Grant | $0.00 | +8,963 | 8,963 | New | $0 |
| DA | 2023-06-16 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +39.5K | 88.3K | +81% | $0 |
| DA | 2023-06-16 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | F - Tax | $28.46 | -4,216 | 84.1K | -5% | -$120.0K |
| DM | 2023-06-16 | 2023-06-14+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $18.65 | -37.5K | 79.5K | -32% | -$699.3K |
| DM | 2023-06-16 | 2023-06-14+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.75 | +37.5K | 80.6K | +87% | +$140.7K |
| I | 2023-05-18 | 2023-05-18 | AGL | CD&R Investment Associates IX, Ltd. | 10% | S - Sale | $20.80 | -94.17M | 100.00M | -48% | -$1.96B |
| I | 2023-05-17 | 2023-05-15 | AGL | CD&R Vector Holdings, L.P. | 10% | J - Other | $0.00 | -437.5K | 194.17M | -0.2% | $0 |
| DM | 2023-05-17 | 2023-05-15+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +50.0K | 104.5K | +92% | +$150.0K |
| DM | 2023-05-17 | 2023-05-15+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $23.46 | -50.0K | 79.5K | -39% | -$1.17M |
| D | 2023-05-11 | 2023-05-09 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $26.15 | -4,500 | 299.6K | -1% | -$117.7K |
| D | 2023-05-11 | 2023-05-09 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $3.00 | +4,500 | 304.1K | +2% | +$13.5K |
| DM | 2023-04-21 | 2023-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $3.00 | +5,500 | 304.6K | +2% | +$16.5K |
| DM | 2023-04-21 | 2023-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $26.84 | -5,500 | 299.6K | -2% | -$147.6K |
| DM | 2023-04-19 | 2023-04-17+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $2.93 | +50.0K | 104.5K | +92% | +$146.3K |
| DM | 2023-04-19 | 2023-04-17+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $27.90 | -50.0K | 80.9K | -38% | -$1.39M |
| D | 2023-04-18 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | F - Tax | $28.46 | -4,216 | 79.7K | -5% | -$120.0K |
| D | 2023-04-18 | 2023-04-14 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +35.1K | 83.9K | +72% | $0 |
| 2023-04-18 | 2023-04-14 | AGL | Richards Clay | Dir | A - Grant | $0.00 | +5,622 | 41.2K | +16% | $0 | |
| D | 2023-04-18 | 2023-04-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | A - Grant | $0.00 | +4,393 | 59.8K | +8% | $0 |
| D | 2023-04-18 | 2023-04-14 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | F - Tax | $28.46 | -1,312 | 58.5K | -2% | -$37.3K |
| 2023-04-18 | 2023-04-14 | AGL | Wulf John William | Dir | A - Grant | $0.00 | +5,622 | 129.0K | +5% | $0 | |
| D | 2023-04-18 | 2023-04-14 | AGL | Bensley Timothy | CFO | A - Grant | $0.00 | +11.0K | 38.0K | +41% | $0 |
| D | 2023-04-18 | 2023-04-14 | AGL | Bensley Timothy | CFO | F - Tax | $28.46 | -2,871 | 35.2K | -8% | -$81.7K |
| 2023-04-18 | 2023-04-14 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +5,622 | 6,700 | +522% | $0 | |
| D | 2023-04-18 | 2023-04-14 | AGL | Kasenchak Priscilla | CAO | A - Grant | $0.00 | +4,393 | 7,745 | +131% | $0 |
| 2023-04-18 | 2023-04-14 | AGL | McLoughlin Karen | Dir | A - Grant | $0.00 | +5,622 | 16.0K | +54% | $0 | |
| D | 2023-04-18 | 2023-04-14 | AGL | Shaker Benjamin | Chief Markets Off | F - Tax | $28.46 | -3,043 | 79.5K | -4% | -$86.6K |
| D | 2023-04-18 | 2023-04-14 | AGL | Shaker Benjamin | Chief Markets Off | A - Grant | $0.00 | +22.0K | 82.6K | +36% | $0 |
| 2023-04-18 | 2023-04-14 | AGL | Mansukani Sharad | Dir | A - Grant | $0.00 | +5,622 | 1.24M | +0.5% | $0 | |
| 2023-04-18 | 2023-04-14 | AGL | WILLIAMS RONALD A | Dir | A - Grant | $0.00 | +5,622 | 2.46M | +0.2% | $0 | |
| 2023-04-18 | 2023-04-14 | AGL | Schwaneke Jeffrey A. | Dir | A - Grant | $0.00 | +5,622 | 9,631 | +140% | $0 | |
| D | 2023-04-18 | 2023-04-14 | AGL | Venkatachaliah Girish | CTO | A - Grant | $0.00 | +22.0K | 37.8K | +139% | $0 |
| D | 2023-04-18 | 2023-04-14 | AGL | Venkatachaliah Girish | CTO | F - Tax | $28.46 | -1,357 | 36.4K | -4% | -$38.6K |
| D | 2023-04-18 | 2023-04-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | A - Grant | $0.00 | +26.4K | 303.1K | +10% | $0 |
| D | 2023-04-18 | 2023-04-14 | AGL | Desai Veeral | Chief Strategy, Dev. Off | F - Tax | $28.46 | -3,497 | 299.6K | -1% | -$99.5K |
| DM | 2023-03-27 | 2023-03-23+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $3.00 | +120.0K | 374.0K | +47% | +$360.0K |
| DM | 2023-03-27 | 2023-03-23+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $28.70 | -120.0K | 276.7K | -30% | -$3.44M |
| DM | 2023-03-24 | 2023-03-22+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +16.2K | 63.5K | +34% | +$145.5K |
| DM | 2023-03-24 | 2023-03-22+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $27.94 | -16.2K | 55.4K | -23% | -$452.3K |
| D | 2023-03-17 | 2023-03-15 | AGL | Wulf John William | Dir | S - Sale+OE | $23.82 | -80.0K | 123.4K | -39% | -$1.91M |
| D | 2023-03-17 | 2023-03-15 | AGL | Wulf John William | Dir | M - OptEx | $4.50 | +80.0K | 203.4K | +65% | +$360.0K |
| D | 2023-03-17 | 2023-03-15 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $23.81 | -55.0K | 55.4K | -50% | -$1.31M |
| D | 2023-03-17 | 2023-03-15 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +100.0K | 110.4K | +959% | +$449.0K |
| D | 2023-03-17 | 2023-03-16 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $26.09 | -60.0K | 276.7K | -18% | -$1.57M |
| D | 2023-03-17 | 2023-03-16 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $3.00 | +60.0K | 336.7K | +22% | +$180.0K |
| DM | 2023-03-17 | 2023-03-15+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $24.33 | -85.0K | 81.0K | -51% | -$2.07M |
| DM | 2023-03-17 | 2023-03-15+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $1.00 | +120.0K | 85.6K | New | +$120.0K |
| DM | 2023-03-09 | 2023-03-07+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +16.2K | 18.5K | +694% | +$145.5K |
| DM | 2023-03-09 | 2023-03-07+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $24.40 | -16.2K | 10.4K | -61% | -$395.0K |
| D | 2023-02-22 | 2023-02-17 | AGL | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,078 | 1,078 | New | $0 |
| DM | 2023-02-16 | 2023-02-14+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $1.77 | +78.6K | 56.0K | New | +$139.4K |
| DM | 2023-02-16 | 2023-02-14+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $23.12 | -78.6K | 25.6K | -75% | -$1.82M |
| DM | 2023-02-16 | 2023-02-14+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.99 | -34.0K | 10.4K | -77% | -$781.0K |
| DM | 2023-02-16 | 2023-02-14+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +34.0K | 36.3K | +1,457% | +$305.4K |
| DM | 2023-02-03 | 2023-02-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +36.2K | 15.8K | New | +$325.2K |
| DM | 2023-02-03 | 2023-02-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $22.81 | -36.2K | 10.4K | -78% | -$825.1K |
| DM | 2023-01-23 | 2023-01-19+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $19.79 | -16.2K | 10.4K | -61% | -$320.4K |
| DM | 2023-01-23 | 2023-01-19+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +16.2K | 21.2K | +322% | +$145.5K |
| DM | 2023-01-19 | 2023-01-17+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +46.4K | 46.3K | New | +$139.3K |
| DM | 2023-01-19 | 2023-01-17+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $19.85 | -46.4K | 25.6K | -64% | -$922.0K |
| DM | 2023-01-09 | 2023-01-05+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $15.48 | -5,396 | 10.4K | -34% | -$83.6K |
| DM | 2023-01-09 | 2023-01-05+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $8.99 | +5,396 | 13.1K | +70% | +$48.5K |
| DMA | 2023-01-09 | 2022-12-16 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $5.23 | +5,398 | 15.8K | +52% | +$28.2K |
| DM | 2022-12-19 | 2022-12-15+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $17.12 | -10.8K | 10.4K | -51% | -$184.8K |
| DM | 2022-12-19 | 2022-12-15+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 15.8K | +215% | +$48.5K |
| DM | 2022-12-16 | 2022-12-14+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $17.39 | -37.5K | 25.6K | -59% | -$652.1K |
| DM | 2022-12-16 | 2022-12-14+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +37.5K | 44.4K | +545% | +$112.5K |
| DM | 2022-12-07 | 2022-12-05+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 15.8K | +215% | +$48.5K |
| DM | 2022-12-07 | 2022-12-05+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $17.76 | -10.8K | 10.4K | -51% | -$191.7K |
| I | 2022-11-22 | 2022-11-18 | AGL | Sell Steven | CEO, Pres, Dir | P - Purchase | $17.14 | +2,900 | 2,900 | New | +$49.7K |
| DM | 2022-11-18 | 2022-11-16+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $17.73 | -37.5K | 25.6K | -59% | -$664.9K |
| DM | 2022-11-18 | 2022-11-16+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +37.5K | 44.4K | +545% | +$112.5K |
| DM | 2022-11-18 | 2022-11-16+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 15.8K | +215% | +$48.5K |
| DM | 2022-11-18 | 2022-11-16+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $17.98 | -10.8K | 10.4K | -51% | -$194.0K |
| DM | 2022-11-03 | 2022-11-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $19.78 | -10.8K | 10.4K | -51% | -$213.5K |
| DM | 2022-11-03 | 2022-11-01+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 15.8K | +215% | +$48.5K |
| MA | 2022-10-21 | 2022-10-19+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale | $20.16 | -50.0K | 26.5K | -65% | -$1.01M |
| DM | 2022-10-21 | 2022-10-19+ | AGL | Shaker Benjamin | Chief Markets Off | S - Sale+OE | $20.16 | -50.0K | 25.6K | -66% | -$1.01M |
| DM | 2022-10-21 | 2022-10-19+ | AGL | Shaker Benjamin | Chief Markets Off | M - OptEx | $3.00 | +50.0K | 46.1K | New | +$150.0K |
| DM | 2022-10-18 | 2022-10-14+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +10.8K | 15.8K | +215% | +$48.5K |
| DM | 2022-10-18 | 2022-10-14+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $21.79 | -10.8K | 10.4K | -51% | -$235.2K |
| DM | 2022-10-05 | 2022-10-03+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | S - Sale+OE | $23.72 | -16.2K | 10.4K | -61% | -$384.0K |
| DM | 2022-10-05 | 2022-10-03+ | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $4.49 | +16.2K | 18.5K | +694% | +$72.7K |
| D | 2022-10-05 | 2022-10-03 | AGL | Kasenchak Priscilla | CAO | A - Grant | $0.00 | +3,352 | 3,352 | New | $0 |
| A | 2022-09-29 | 2022-04-14 | AGL | Bensley Timothy | CFO | F - Tax | $23.07 | -1,430 | 27.1K | -5% | -$33.0K |
| A | 2022-09-29 | 2022-04-14 | AGL | Shaker Benjamin | Chief Markets Off | F - Tax | $23.07 | -1,507 | 25.6K | -6% | -$34.8K |
| A | 2022-09-29 | 2022-04-14 | AGL | Sobotka Glenn | CAO | F - Tax | $23.07 | -334 | 5,365 | -6% | -$7,705 |
| A | 2022-09-29 | 2022-04-14 | AGL | Venkatachaliah Girish | CTO | F - Tax | $23.07 | -476 | 15.8K | -3% | -$11.0K |
Purchase Sale Sale after option exercise All abbreviations